Acer Medical Inc. (TPEX:6857)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
98.00
-1.50 (-1.51%)
Apr 2, 2026, 12:32 PM CST
Market Cap1.49B -31.2%
Revenue (ttm)55.10M +21.6%
Net Income-30.32M
EPS-1.99
Shares Out15.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,914
Average Volume1,962
Open98.00
Previous Close99.50
Day's Range98.00 - 98.00
52-Week Range97.00 - 158.50
Beta0.95
RSI41.83
Earnings DateApr 17, 2026

About Acer Medical

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 2018
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6857
Full Company Profile

Financial Performance

In 2024, Acer Medical's revenue was 50.16 million, an increase of 82.73% compared to the previous year's 27.45 million. Losses were -27.36 million, -28.33% less than in 2023.

Financial Statements